COMPANY PROFILE

Restore Medical

Explore full profile

Restore Medical has developed a device which restore heart function in patients with Congestive Heart Failute (CHF)

Or Yehuda, IsraelFounded 2016Health Tech & Medtech

Valuation $0–100M Latest valuation · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Restore Medical

Developer of a device-based therapy designed to provide treatment for patients with congestive heart failure. The company develops catheter-delivered implant, for patients with left ventricle failure that improves LV ejection fraction, reduces mitral regurgitation, and restores favorable ventricular geometry, enabling patients with quality-of-life and reducing hospital readmission rates. Keywords: Healthcare Devices, Services, Supplies, Catheter-Delivered Implants, Congestive Heart Failure, Device-Based Therapy, Ejection Fraction, Medical Device Development, Ventricular Geometry.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Or Yehuda, Israel
Employees: 17
Open positions: None listed
Dealroom signal: 83.8/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Arts & Culture, EIC, EIC Fund, Hard Tech, Horizon Europe
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Latest news

Press, funding announcements and product moves mentioning Restore Medical.

See all news

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Jul 2025	$23M	$92M	Peregrine Ventures · EIC Fund · Pitango Venture Capital	↗
GRANT✓Other financing	Mar 2022	$2.5M	—	European Innovation Council	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Restore Medical website traffic

Latest recorded traffic for Restore Medical is 3.1K monthly website visits, up 2718.2% over the last three months. Restore Medical's team grew 21.4% over the past year.

Latest monthly visits3.1K 3-month web change+2718.2% 1-year team growth+21.4%

Monthly website visitsNov 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CYCYTO365The medical multi inlet turn valve manifold that prevent mixing of drugs	Helsingborgs kommun, Sweden	Operational	9	$2.3M	$31M
CSCardiac SuccessCardiac Success is developing the V-sling device to help patients with Heart Failure with Reduced Ejection Fraction. The V-sling is a transcatheter ventricular repair device based on surgery	Nof HaGalil, Israel	Operational
SESensiusSensius is focused on establishing thermotherapy as a key treatment modality for cancer patients alongside radiotherapy, surgery, chemotherapy, and immunotherapy	Rotterdam, Netherlands	Operational
.L.lumenWearable autonomous driving system for visually impaired individuals	Cluj-Napoca, Romania	Operational
GRGanymed RoboticsGanymed retools orthopaedics with robotics. Their product is a compact, ergonomic, and cost-effective joint-replacement device. The robot's intelligence and perception are driven by computer vision	Paris, France	Operational
AMAMT MedicalDeveloping minimally invasive technology for coronary artery bypass surgery	Ede, Netherlands	Operational
PLPlasmaCureUses cold atmospheric plasma on chronic wounds to generate reactive species that deliver antimicrobial effects and promote tissue regeneration	Eindhoven, Netherlands	Operational
COCorWaveCorWave develops innovative implantable blood pumps based on a breakthrough membrane technology	Clichy, France	Operational